Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Meet criteria for primary alcohol dependence including loss of control of drinking~* No more than one previous inpatient medical detoxification~* Consumes on average 5 standard drinks for men and 4 standard drinks for women~* Able to maintain sobriety for 4 days (with or without detox medications).~* Able to read and understand questionnaires and Informed Consent~* Lives within 50 miles of the study site~Exclusion Criteria:~* Currently meets DSM-IV criteria for any other psychoactive substance dependency disorder except nicotine dependence~* Ever abused opiates~* Any psychoactive substance abuse, except marijuana and nicotine within the last 30 days as evidenced by subject report, collateral report, or urine drug screen.~* Meets DSM-IV criteria for current Axis I disorder of major depression, panic disorder, obsessive-compulsive disorder, post-traumatic stress syndrome, bipolar affective disorder, dissociative disorder or eating disorder, schizophrenia, or any other psychotic disorder or organic mental disorder.~* Has current suicidal or homicidal ideation~* Need for maintenance or acute treatment with any psychoactive medication including antiseizure medications.~* Current use of disulfiram.~* Clinically significant medical problems, such as cardiovascular, renal, GI or endocrine problem that would impair participation or limit medication ingestion.~* Hepatocellular disease indicated by elevations of SGPT (ALT) and SGOT (AST) of at least 3.0 times normal at screening and/or after 5 days of abstinence.~* Sexually active females of child bearing potential who are pregnant (by urine HCG), nursing or who are not using a reliable form of birth control.~* Has current charges pending for a violent crime (not including DUI related offenses).~* Does not have a stable living situation and a reliable source of collateral reporting.~* Has taken an opiate antagonist drug in the last month.~* Has taken gabapentin in the last month or has experienced adverse effects from it at any time in the past.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Naltrexone plus placebo
- 2 (Type: ACTIVE_COMPARATOR): naltrexone + gabapentin
- 3 (Type: SHAM_COMPARATOR): Placebo plus placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).